(Editor’s Note: this is Part 2 of the new 3‑part series written by Dr. Evian Gordon drawing from his participation at the Personalized Medicine World Congress on January, 23, 2012 at Stanford University.)
Most Personalized Medicine research in Psychiatry using molecular measures alone have failed to replicate. Whilst disappointing, this is not surprising, since 80% of human 25,000 genes have some effect on the brain.
There are therefore growing efforts expanding Genomic Biomarkers in Psychiatry to Neuroimaging (all Brain-based biological and cognitive measures). Some approaches target [Read more…] about Personalized Medicine in Psychiatry: from DSM to brain-based RDoC, iSPOT‑D and biomarkers